Beat The Denominator

Consider Hims & Hers Health (HIMS) as an undervalued opportunity, as the market is overly focused on its smaller weight-loss drug segment while ignoring potential catalysts like new product launches. Nebius (NBIS) is presented as an extremely cheap pure-play AI data center operator, with forecasts predicting 10x to 20x revenue growth over the next 12 months. An upcoming announcement about converting a mining site to GPU compute for AI could be a major catalyst for Bitcoin miner CleanSpark (CLSK). The long-term thesis for Tesla (TSLA) is its transformation into a high-margin subscription business through its Full Self-Driving (FSD) monthly model. Finally, consider adding Southeast Asian super-app Grab Holdings (GRAB) to your watchlist, as it becomes an attractive deep value play if the price falls towards the $3 range.

For long-term investors, consider holding Bitcoin (BTC) with a potential price target of $500,000 to $1,000,000 by the 2030s. To gain leveraged exposure to Bitcoin through the stock market, MicroStrategy (MSTR) is presented as a high-conviction investment that has recently outperformed the underlying asset. For those with a higher risk tolerance, Solana (SOL) is a "higher beta" alternative that offers more exaggerated price movements in both directions. The broader theme of Digital Asset Treasuries (DATs), or companies holding crypto, is expected to perform well as the market rebounds. These volatile assets are best approached with a long-term mindset, as short-term price movements are highly unpredictable.

Consider accumulating MicroStrategy (MSTR) stock, as the company is aggressively using its equity to acquire Bitcoin in a strategy the market is rewarding. The current period is viewed as a key accumulation phase for Bitcoin (BTC) itself, with major institutions advising clients to buy before an anticipated price increase. MSTR offers a strategic way to gain exposure to Bitcoin, as its recent stock outperformance suggests investors approve of its active accumulation strategy. The long-term outlook for Bitcoin is very bullish, with some analysts looking towards 2026 for significant price appreciation. By issuing stock to buy BTC, MSTR is also making its corporate debt significantly safer, which strengthens the company's overall financial health for equity investors.

Consider buying Hims & Hers Health (HIMS), as recent fears about competition in the weight loss market appear to be an overreaction. The market overlooks that HIMS is a diversified telehealth platform, with over 70% of its revenue coming from established streams like erectile dysfunction and mental health treatments. Its primary advantage is a unique all-in-one subscription that bundles the doctor's visit and medication, removing financial risk for consumers. Competitors like Amazon (AMZN) have a weaker model, as their lower prices exclude the significant hidden cost and inconvenience of a separate doctor's consultation. This superior, risk-free business model provides HIMS with a strong competitive moat, presenting a compelling investment opportunity.

Consider the MicroStrategy preferred stock (STRC) for a stable, high-yield investment, currently paying an 11% tax-deferred return for approximately nine years. The instrument is engineered to trade at $100 as the company actively sells shares to maintain this price level during market hours. This new funding vehicle is a significant positive for MicroStrategy's common stock (MSTR), which has recently begun to outperform Bitcoin. The success of STRC could reduce the need for MSTR to issue new common stock, a factor the market may view favorably. For Bitcoin (BTC) itself, the core advice is to ignore short-term price volatility and maintain a long-term holding strategy with at least a four-year horizon.

Consider the key difference between healthcare companies that sell directly to consumers versus those dependent on government payers. Hims & Hers (HIMS) is highlighted as a potentially safer investment due to its direct-to-consumer model, with the recent price drop viewed as a potential buying opportunity. In contrast, CorMedix (CRMD) is presented as a high-risk, high-reward value play after its stock crashed over 30%. The company is considered "dirt cheap" but faces significant uncertainty from a Medicare pricing renegotiation for its key product in late 2026. For investors with a high risk tolerance, CRMD offers a value proposition, while HIMS provides a growth opportunity with a more resilient business model.

For long-term investors, MicroStrategy (MSTR) is presented as a high-conviction bet on the success of Bitcoin, with a suggested holding period until at least 2030. Investors seeking high income could consider the preferred stock STRC, which aims to provide a stable $100 price point with a high, tax-deferred dividend of around 11%. The strong demand for STRC is seen as a bullish indicator for MSTR, as it provides a powerful way for the company to raise capital to acquire more Bitcoin. The core thesis for both investments relies on the long-term appreciation of Bitcoin, which should be viewed as a long-term hold of at least four years. Investors should ignore short-term price volatility and technical analysis, as this strategy is intended for a multi-year time horizon.

Consider Tesla (TSLA) as a long-term investment in AI and robotics, viewing current weakness as a buying opportunity that looks beyond short-term car sales. Hims & Hers Health (HIMS) is presented as a significantly undervalued growth stock, disrupting healthcare with strong underlying business performance. For a high-growth real estate investment, The Real Brokerage Inc. (REAX) is identified as a "dirt cheap" and profitable company with a superior, low-capital business model. For investors with a high risk tolerance, Nebius (NBIS) offers hyper-growth potential of over 1,500% due to its strategic partnership with NVIDIA. These opportunities are based on long-term theses where the market is believed to be mispricing future potential.

Bitcoin (BTC) is viewed as a "coiled spring" ready for a significant price increase after breaking a negative 3-month trading pattern. The primary advice is to own the asset now, as timing the expected breakout is considered impossible. MicroStrategy's (MSTR) recent strategy of raising cash and buying Bitcoin is designed to support its new preferred stock, "Stretch" (STRC). Investors should watch STRC closely, as a sustained price above $100 is a critical catalyst for the company's next phase. With downward pressure easing, the speaker sees significant upside for Bitcoin, with a price of $94,000 mentioned as a potential short-term target.

Consider holding Bitcoin (BTC) as a core position, as it is presented as a resilient asset that tends to outperform other cryptocurrencies during market stress. In a risk-off environment, be aware that capital may flow from altcoins like ETH, SOL, and ADA into the relative safety of Bitcoin. For long-term investors, the key bullish catalyst for MicroStrategy (MSTR) is its future plan to issue Bitcoin-backed bonds, making short-term index inclusion news less relevant. Monitor geopolitical developments related to Venezuela, as increased access to its reserves could be a significant positive catalyst for major oil stocks like Exxon (XOM) and Chevron (CVX). Conversely, this same event could create headwinds for US shale oil and Canadian oil producers.

Consider adding to Hims & Hers (HIMS) and MicroStrategy (MSTR) at current levels, as both are viewed as presenting immediate buying opportunities. For MSTR, the analysis suggests a potential to reclaim the $300 and then $400 price levels as a leveraged play on Bitcoin. NVIDIA (NVDA) is considered extremely undervalued relative to its projected 10x-20x revenue growth over the next 12 months, driven by the AI boom. Similarly, CleanSpark (CLSK) is seen as "way too cheap" and mispriced by the market, despite its high-growth profile. The core long-term thesis is that scarce assets like Bitcoin (BTC) will continue to rise as fiat currencies are devalued, suggesting it will not remain at five-figure prices for long.

Consider Strategic Education, Inc. (STRA), which is showing strong bullish momentum after breaking the key $100 price level. This move may signal a broader market rotation into small-cap stocks as capital moves away from struggling mega-caps. Bitcoin (BTC) is also demonstrating surprising resilience and maturity, holding strong around $90,000 despite major geopolitical events. This strength suggests Bitcoin could be evolving into a potential hedge against certain types of geopolitical instability. For long-term investors, prepare to use expected market volatility leading into 2026 as a buying opportunity for positions held into the 2030s.

For income investors, MicroStrategy's preferred instrument STRC offers an 11% yield and is expected to trade near its $100 target price. This investment is supported by an anticipated Federal Reserve rate cut within the next 90 days, which would make its high yield more attractive. This rate cut is part of a broader fiat debasement theme, strengthening the long-term case for hard assets like Bitcoin (BTC). Consider holding Bitcoin (BTC) as a primary long-term investment to hedge against this monetary expansion. For a higher-risk, leveraged bet on Bitcoin, MicroStrategy (MSTR) stock is an option for investors with a 4+ year time horizon.

View Tesla (TSLA) as a long-term cornerstone investment in AI and robotics, with its primary value derived from future businesses like Robotaxi and Optimus. For a concentrated bet on the success of Bitcoin, consider MicroStrategy (MSTR) as a direct proxy and a hedge against the traditional financial system. Hims & Hers Health (HIMS) is presented as a current "bargain" for its potential to disrupt healthcare with its AI Doctor and pharmacy model that operates outside of insurance. These opportunities are high-conviction investments centered on the theme of AI-driven disruption across the transportation, finance, and healthcare sectors. Investors should approach these stocks with a long-term perspective, potentially holding beyond 2030 to realize their full potential.